Skip to main content
Clinical Trials/NCT04792905
NCT04792905
Completed
Not Applicable

Étude Exploratoire Des Performances de Diagnostic Électrocardiographique de l'Apple Watch augmentée d'un Algorithme d'Intelligence Artificielle

Cardiologs Technologies1 site in 1 country200 target enrollmentMarch 30, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atrial Fibrillation
Sponsor
Cardiologs Technologies
Enrollment
200
Locations
1
Primary Endpoint
Performance of AF detection
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This observational exploratory prospective study will evaluate the performance on an Artificial Intelligence (AI) solution interpreting ECG (electrocardiogram) collected from an Apple Watch (AI-AW) in the detection of Atrial Fibrillation (AF)

Detailed Description

After being informed about the study, participants hospitalized for ablation or cardioversion or having a cardiac rhythm consultation at the investigational center will have Apple Watch ECG recordings done simultaneously with 12-lead ECG measurements performed in accordance with the existing in-stay subject monitoring protocol. AI-AW will be compared to standard manual 12-lead ECG reviewed by cardiologists for AF detection.

Registry
clinicaltrials.gov
Start Date
March 30, 2021
End Date
July 19, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Cardiologs Technologies
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient aged 22 or older, able and willing to participate in the study
  • Patient admitted to hospital for ablation, cardioversion or cardiac electrophysiological exploration or who come for regular rhythmology consultations
  • Patient who has read the information note and has given his or her consent before any procedure related to the study
  • Patient affiliated to social security

Exclusion Criteria

  • Pregnant or breastfeeding women
  • Patient with a pacemaker, implantable defibrillator or cardiac resynchronisation therapy device.
  • Subject related to the investigator or any other staff member directly involved in the conduct of the study
  • Patient incapable of giving consent, minor or adult patient protected by law

Outcomes

Primary Outcomes

Performance of AF detection

Time Frame: 1 day

Performance of AF detection by an artificial intelligence (AI) solution interpreting ECG collected via Apple Watches (AI-AW), compared to physician's diagnosis from the 12 leads ECG

Secondary Outcomes

  • AW versus AI-AW(1 day)
  • AI-AW versus AI-12lead(1 day)

Study Sites (1)

Loading locations...

Similar Trials